Skip to content

Transcranial ultrasonic stimulation of the primary motor cortex

Transcranial ultrasonic stimulation of the primary motor cortex - Transcranial ultrasonic stimulation of the primary motor cortex

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51013
Enrollment
12
Registered
2021-06-22
Start date
2021-11-01
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroscience research (basic science) brain

Interventions

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Between 18-40 years of age - Right handed - The ability and agreement to provide informed consent, and the ability to fulfil the study's requirements

Exclusion criteria

Exclusion criteria: * Under 18 years of age * Current or planned pregnancy * Claustrophobia * A history or brain surgery or serious head trauma * A history of or any close relatives (parents, siblings, children) with epilepsy, convulsion, or seizure * Predisposition for fainting spells (syncope) * A cardiac pacemaker or intra-cardiac lines * An implanted neurostimulator * Implanted medication infusion device * Implanted metal devices or large ferromagnetic fragments in the head or upper body (excluding dental wire), or jewellery/piercing that cannot be removed * Use of a medical plaster that cannot or may not be taken off (e.g., nicotine plaster) * Cochlear implants * Metal in the brain, skull, or elsewhere in your body (fragments, clips, etc.) * Diagnosed neurological or psychiatric disorders * Use of psychoactive (prescription) medication (excluding anti-conception) * Skin disease at intended stimulation sites * The consumption of more than four alcoholic units within 24 hours before participation or any recreational drugs within 48 hours before participation * All other criteria relevant to non-invasive brain stimulation as reported in the Donders Standard Operating Procedures for Non-Invasive Brain Stimulation

Design outcomes

Primary

MeasureTime frame
We will use electromyography (EMG) to measure motor-evoked potentials (MEPs) over the first dorsal interosseous (FDI) elicited by TMS applied over M1. Here, MEP peak-to-peak amplitude is our primary outcome measure.

Secondary

MeasureTime frame
Our secondary outcome is establishing the technical feasibility of combining TMS and TUS. Here, we will test the technical operation of the combined TMS-TUS equipment and write a technical report on its operation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)